KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Finished Goods (2016 - 2019)

Jazz Pharmaceuticals has reported Finished Goods over the past 10 years, most recently at $22.3 million for Q1 2019.

  • Quarterly Finished Goods changed N/A to $22.3 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $22.3 million through Mar 2019, changed N/A year-over-year, with the annual reading at $21.3 million for FY2018, 11.22% down from the prior year.
  • Finished Goods was $22.3 million for Q1 2019 at Jazz Pharmaceuticals, up from $21.3 million in the prior quarter.
  • Over five years, Finished Goods peaked at $24.0 million in Q4 2017 and troughed at $5.0 million in Q4 2015.
  • The 5-year median for Finished Goods is $17.9 million (2018), against an average of $16.0 million.
  • Biggest five-year swings in Finished Goods: tumbled 69.83% in 2015 and later skyrocketed 175.91% in 2016.
  • Tracing JAZZ's Finished Goods over 5 years: stood at $5.0 million in 2015, then skyrocketed by 175.91% to $13.8 million in 2016, then surged by 73.8% to $24.0 million in 2017, then dropped by 11.22% to $21.3 million in 2018, then rose by 4.68% to $22.3 million in 2019.
  • According to Business Quant data, Finished Goods over the past three periods came in at $22.3 million, $21.3 million, and $17.9 million for Q1 2019, Q4 2018, and Q2 2018 respectively.